Clinical Trials Browser

Phase 1 × Advanced Cancer × Irinotecan × Clear all

NCT01347866 2018-10-29

Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Phase 1 Terminated

105 enrolled 64 charts

Advanced Cancer

NCT00708773 2017-01-04

Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer